Related Experiment Video

Updated: May 18, 2026

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
12:21

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer

Shao-Wen Hung1, Ching-Feng Chiu, Tai-An Chen

  • 1Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan.

Breast Cancer Research and Treatment
|September 18, 2012
PubMed

Insights

Recombinant viral capsid protein VP1 (rVP1) inhibits breast cancer metastasis by suppressing cell migration and HER-2 expression. This protein shows potential as a therapeutic for metastatic breast cancer, particularly HER-2-positive types, with no observed side effects.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Breast cancer metastasis is a primary cause of mortality, necessitating novel therapeutic strategies.
  • Human epidermal growth factor receptor 2 (HER-2) is a key biomarker associated with poor prognosis in breast cancer.

Purpose of the Study:

  • To investigate the inhibitory effects of recombinant viral capsid protein VP1 (rVP1) on breast cancer cell migration, invasion, and metastasis.
  • To explore the impact of rVP1 on HER-2 expression and related signaling pathways in breast cancer.

Main Methods:

  • In vitro assays (Transwell migration) and in vivo animal models (orthotopic allograft/xenograft) were used to evaluate metastasis inhibition.
  • Molecular techniques including Western blotting, RT-PCR, flow cytometry, immunohistochemistry, and immunofluorescence staining were employed.
  • Assessment of rVP1's effects on HER-2 expression, AP-2α, β1-integrin, and overall mouse survival and safety.

Main Results:

  • rVP1 suppressed migration, invasion, and metastasis of various breast cancer cell lines, including HER-2-overexpressing cells, in vitro and in vivo.
  • rVP1 induced mesenchymal-epithelial transition and downregulated AP-2α and HER-2 expression in a β1-integrin-dependent manner.
  • rVP1 treatment significantly prolonged survival in tumor-bearing mice without apparent toxicity.

Conclusions:

  • rVP1 effectively suppresses breast cancer cell migration, invasion, and metastasis by targeting β1 integrin and downregulating AP-2α and HER-2.
  • rVP1 demonstrates therapeutic potential for metastatic breast cancer, especially HER-2-overexpressing subtypes, with a favorable safety profile.

More Related Videos

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems13:47

Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems

Published on: April 23, 2012

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...